Maslimomab
From Wikipedia, the free encyclopedia
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Mouse |
| Target | T-cell receptor |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number |
|
| ChemSpider |
|
 N Y (what is this?) | |
Maslimomab is a mouse monoclonal antibody[1] and an immunosuppressive drug.[citation needed]
References[]
show
| |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracellular (initiation) |
| ||||||||||||||
| Intracellular (reception) |
| ||||||||||||||
| Extracellular |
| ||||||||||||||
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by . |
- v
- t
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Drugs not assigned an ATC code
- Monoclonal antibodies
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs
Hidden categories:
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugs that are a monoclonal antibody
- All articles with unsourced statements
- Articles with unsourced statements from September 2009
- All stub articles